Beishen Pharmaceutical

Wuhan Beishen Pharmaceutical Co., Ltd. (abbreviated as "Beishen Pharmaceutical"), formerly Wuhan Jinlian Pharmaceutical Co., Ltd., is a modern pharmaceutical enterprise featuring traditional Chinese medicine production and focusing on pediatric medication as its core products. The company was officially listed on the New Third Board in September 2017 (stock code: 871910). Beishen Pharmaceutical currently has six dosage forms including oral liquid, syrup, decoction paste, granules, tablets, and powders, and owns multiple exclusively produced core products listed in the National Medical Insurance, such as Compound Radix Pseudostellariae Cough-Relieving and Qi-Benefiting Powder and Xing Su Cough-Relieving Syrup. The company's core strategic product — Compound Radix Pseudostellariae Cough-Relieving and Qi-Benefiting Powder — is mainly used for recurrent respiratory tract infections and asthma. Clinical verification shows a cure rate of 58.5% for pediatric asthma, possessing tremendous social and economic value. This product has obtained a national patent certificate (Patent No.: ZL93104773.0) and has been included in the *Spark Program. After 17 years of steady development, Beishen Pharmaceutical has grown into a modern enterprise integrating R&D, production, quality inspection, warehousing, and marketing, with an annual output value of approximately 2 billion yuan. The company employs top domestic scientific research experts, is equipped with internationally advanced laboratory equipment, and collaborates with scientific research institutions — the Drug Research Institute of Tongji Medical University — to continuously advance products along new technological directions. In the next 5-8 years, Beishen Pharmaceutical will be committed to building a pediatric medication base. In addition to producing exclusive products such as Compound Radix Pseudostellariae Cough-Relieving and Qi-Benefiting Powder and Infant Diarrhea-Stopping Granules, it will also develop pediatric medications such as Vitamin Syrup and Anti-Allergy Oral Liquid, gradually establishing the industry brand effect of a pediatric medication production base. Beishen Pharmaceutical adheres to the corporate mission of "Promoting National Medicine, Spreading Health Culture" and takes "Carrying Forward Traditional Chinese Medicine Characteristics, Being a Pediatric Medication Expert" as its strategic goal, caring about the healthy growth of every child. Corporate Mission: Promote national medicine, spread health culture. Corporate Vision: Carry forward traditional Chinese medicine characteristics, be a pediatric medication expert. Service Philosophy: With full enthusiasm, meet customer needs.